HomeNewsIndiaDemand in economy will rise when uncertainty is not there: CEA Krishnamurthy V Subramanian

Demand in economy will rise when uncertainty is not there: CEA Krishnamurthy V Subramanian

According to Krishnamurthy V Subramanian, this uncertainty arising out of the health factor will stay until a vaccine for COVID-19 is developed, and spending will not pick up till then.

June 19, 2020 / 20:42 IST
Story continues below Advertisement

Demand in the economy will increase when the uncertainty regarding health in the wake of COVID-19 outbreak ends, Chief Economic Advisor Krishnamurthy V Subramanian said on Friday.

Speaking at a webinar session organised by Bharat Chamber of Commerce, Subramanian said that discretionary spending in the economy has not risen due to uncertainty regarding health in the wake of the coronavirus outbreak.

Story continues below Advertisement

Unlike in countries such as the US where people buy food after getting cash transfers, the scenario is different in India.

"In India, we have a public distribution system which provides food to the people. So, people in our country resort to precautionary motive due to uncertainty," he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show